全文获取类型
收费全文 | 1962篇 |
免费 | 139篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 121篇 |
妇产科学 | 29篇 |
基础医学 | 224篇 |
口腔科学 | 51篇 |
临床医学 | 138篇 |
内科学 | 426篇 |
皮肤病学 | 21篇 |
神经病学 | 122篇 |
特种医学 | 59篇 |
外科学 | 398篇 |
综合类 | 38篇 |
一般理论 | 13篇 |
预防医学 | 91篇 |
眼科学 | 52篇 |
药学 | 174篇 |
中国医学 | 2篇 |
肿瘤学 | 132篇 |
出版年
2023年 | 12篇 |
2022年 | 27篇 |
2021年 | 122篇 |
2020年 | 43篇 |
2019年 | 88篇 |
2018年 | 96篇 |
2017年 | 65篇 |
2016年 | 70篇 |
2015年 | 73篇 |
2014年 | 114篇 |
2013年 | 106篇 |
2012年 | 176篇 |
2011年 | 134篇 |
2010年 | 63篇 |
2009年 | 55篇 |
2008年 | 92篇 |
2007年 | 89篇 |
2006年 | 71篇 |
2005年 | 61篇 |
2004年 | 43篇 |
2003年 | 46篇 |
2002年 | 47篇 |
2001年 | 25篇 |
2000年 | 30篇 |
1999年 | 26篇 |
1998年 | 11篇 |
1996年 | 7篇 |
1995年 | 8篇 |
1994年 | 6篇 |
1992年 | 12篇 |
1991年 | 19篇 |
1990年 | 18篇 |
1989年 | 19篇 |
1988年 | 19篇 |
1987年 | 11篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1978年 | 7篇 |
1976年 | 8篇 |
1974年 | 9篇 |
1973年 | 9篇 |
1972年 | 9篇 |
1971年 | 17篇 |
1970年 | 9篇 |
1967年 | 10篇 |
排序方式: 共有2107条查询结果,搜索用时 31 毫秒
31.
32.
33.
34.
Rajiv Bharat Kharwar M.D. Rishi Sethi M.D. D.M. F.A.C.C. Varun Shankar Narain M.D. D.M. 《Echocardiography (Mount Kisco, N.Y.)》2013,30(10):E322-E325
Endomyocardial fibrosis is a form of restrictive cardiomyopathy mainly affecting poor children and young adults in geographically restricted areas of Latin America, Africa, and Southeast Asia. The pathophysiological hallmark of the disease is focal or diffuse endocardial thickening involving mainly the inflow, the apices, and the subvalvular region leading to valvular regurgitation, diastolic dysfunction and obliteration of the ventricular apex. Advanced right‐sided disease has slow flow of blood through chambers with propensity of thrombus formation especially in the right atria. Although two‐dimensional transthoracic echocardiography remains the cornerstone for the diagnosis of this disease, the case presented here shows how three‐dimensional transthoracic echocardiography can add substantial information regarding the region of involvement of the right ventricle as well as the various characteristics of the right atrial thrombus. 相似文献
35.
Vaibhav R. Vaidya MBBS Suartcha Prueksaritanond MD John P. Bois MD Abhinav Nadipalli MBBS Daniel D. Borgeson MD Rowlens M. Melduni MD MPH 《Echocardiography (Mount Kisco, N.Y.)》2017,34(11):1708-1711
Among patients undergoing cardioversion for atrial fibrillation, the presence of left ventricular thrombus is a relatively uncommon and challenging clinical dilemma. While left atrial appendage thrombus is a contraindication to cardioversion, there is paucity of data regarding the safety of cardioversion in with the presence of left ventricular apical thrombus. Also, thrombus characteristics such as protrusion and mobility on echocardiography are known risk factors for systemic embolism. In this article, we present a case highlighting the management of atrial fibrillation in the setting of left ventricular dysfunction, acute heart failure, and echocardiographic evidence of acute left ventricular apical thrombus. 相似文献
36.
Varun Aggarwal Sebastian C. Tume Marco Rodriguez Iki Adachi Antonio G. Cabrera Hari Tunuguntla Athar M. Qureshi 《Congenital heart disease》2019,14(6):1130-1137
Objective: Predictors of right ventricle (RV) dysfunction after continuous‐flow left
ventricular assist device (CF‐LVAD) implantation in children are not well described.
We explored the association of preimplantation Pulmonary Artery Pulsatility index
(PAPi) and other hemodynamic parameters as predictors of prolonged postoperative
inotropes/pulmonary vasodilator use after CF‐LVAD implantation.
Design: Retrospective chart review.
Setting: Single tertiary care pediatric referral center.
Patients: Patients who underwent CF‐LVAD implantation from January 2012 to October 2017.
Interventions: Preimplantation invasive hemodynamic parameters were analyzed to evaluate the association with post‐CF‐LVAD need for prolonged (>72 hours) use of inotropes/pulmonary vasodilators.
Measurements and main results: Preimplantation cardiac catheterization data was available for 12 of 44 patients who underwent CF‐LVAD implant during the study period. Median (IQR) age and BSA of the cohort were 15.3 years (10.2, 18) and 1.74 m2 (0.98, 2.03). Group 1 (n = 6) included patients with need for prolonged inotropes/pulmonary vasodilator use after CF‐LVAD implantation and Group 2 (n = 6) included those without. Baseline demographic parameters, cardiopulmonary bypass time, and markers of RV afterload (pulmonary vascular resistance, PA compliance and elastance) were similar among the two groups. PAPi was significantly lower in group 1 compared to group 2 (0.96 vs 3.6, respectively; P = .004). Post‐LVAD stay in the intensive care unit was longer for patients in group 1 (46 vs 23 days, P = .52). Brain natriuretic peptide was significantly higher at 3 months after implantation in group 1; P = .01.
Conclusions: The need for inotropes/pulmonary vasodilators in the postoperative period can be predicted by the preimplantation intrinsic RV contractile reserve as assessed by PAPi rather than the markers of RV afterload. Further investigation and correlation with clinical outcomes is needed. 相似文献
Design: Retrospective chart review.
Setting: Single tertiary care pediatric referral center.
Patients: Patients who underwent CF‐LVAD implantation from January 2012 to October 2017.
Interventions: Preimplantation invasive hemodynamic parameters were analyzed to evaluate the association with post‐CF‐LVAD need for prolonged (>72 hours) use of inotropes/pulmonary vasodilators.
Measurements and main results: Preimplantation cardiac catheterization data was available for 12 of 44 patients who underwent CF‐LVAD implant during the study period. Median (IQR) age and BSA of the cohort were 15.3 years (10.2, 18) and 1.74 m2 (0.98, 2.03). Group 1 (n = 6) included patients with need for prolonged inotropes/pulmonary vasodilator use after CF‐LVAD implantation and Group 2 (n = 6) included those without. Baseline demographic parameters, cardiopulmonary bypass time, and markers of RV afterload (pulmonary vascular resistance, PA compliance and elastance) were similar among the two groups. PAPi was significantly lower in group 1 compared to group 2 (0.96 vs 3.6, respectively; P = .004). Post‐LVAD stay in the intensive care unit was longer for patients in group 1 (46 vs 23 days, P = .52). Brain natriuretic peptide was significantly higher at 3 months after implantation in group 1; P = .01.
Conclusions: The need for inotropes/pulmonary vasodilators in the postoperative period can be predicted by the preimplantation intrinsic RV contractile reserve as assessed by PAPi rather than the markers of RV afterload. Further investigation and correlation with clinical outcomes is needed. 相似文献
37.
38.
39.
40.
Yong Tao Byunghak Kang Daniel A. Petkovich Yuba R. Bhandari Julie In Genevieve Stein-OBrien Xiangqian Kong Wenbing Xie Nicholas Zachos Shinji Maegawa Himani Vaidya Stephen Brown Ray-Whay Chiu Yen Xiaojian Shao Jai Thakor Zhihao Lu Yi Cai Yuezheng Zhang Hariharan Easwaran 《Cancer cell》2019,35(2):315-328.e6